On page 837 of the article by Woolston et al.,1 in the sentence reproduced below, “ibrutinib” should be replaced with “acalabrutinib”:
Incorrect sentence:
“Sample R002-A was collected after 3 months of combination therapy with ibrutinib and venetoclax.”
Correct sentence:
“Sample R002-A was collected after 3 months of combination therapy with acalabrutinib and venetoclax.”
Footnotes
- Received January 25, 2024
- Accepted January 25, 2024
Correspondence
References
- Woolston DW, Lee ND, Shadman M. Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies. Haematologica. 2024; 109(3):835-845. https://doi.org/10.3324/haematol.2023.283372PubMedPubMed CentralGoogle Scholar
Figures & Tables
Article Information
Pubmed
Pubmed Central
Published
2024-07-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
Copyright & Usage
Copyright (c) 2024 Ferrata Storti Foundation
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Article Usage
Online Views
456
PDF Downloads
211
Statistics from Altmetric.com
No Data